Adjuvant Chemotherapy With Sequential Cytokine-Induced Killer (CIK) Cells in Stage IB Non-Small Cell Lung Cancer

For non-small cell lung cancer (NSCLC) patients at stage IB, adjuvant chemotherapy does not improve survival. Evidence suggests that dendritic cell (DC)-activated cytokine-induced killer (DC-CIK) cell therapy in addition to chemotherapy improves survival for stage I–IIIA NSCLC patients after surgery...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Da-Peng, Li, Wei, Feng, Jun, Chen, Kai, Tao, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cognizant Communication Corporation 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838450/
https://www.ncbi.nlm.nih.gov/pubmed/25706393
http://dx.doi.org/10.3727/096504014X14024160459168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838450/
https://www.ncbi.nlm.nih.gov/pubmed/25706393
http://dx.doi.org/10.3727/096504014X14024160459168

Ejemplares similares